Cyclic stretch of hESC-CMs provides a viable in vitro human model for studying the molecular mechanisms of cardiac hypertrophy.
Answers are grounded in this paper and cite their sources.
May advance in vitro modeling of hypertrophy mechanisms; leaves open translation to human disease.
Cardiac hypertrophy accompanies many forms of cardiovascular diseases. The mechanisms behind the development and regulation of cardiac hypertrophy in the human setting are poorly understood, which can be partially attributed to the lack of a human cardiomyocyte-based preclinical test system recapitulating features of diseased myocardium. The objective of our study is to determine whether human embryonic stem cell-derived cardiomyocytes (hESC-CMs) subjected to mechanical stretch can be used as an adequate in vitro model for studying molecular mechanisms of cardiac hypertrophy. We show that hESC-CMs subjected to cyclic stretch, which mimics mechanical overload, exhibit essential features of a hypertrophic state on structural, functional, and gene expression levels. The presented hESC-CM stretch approach provides insight into molecular mechanisms behind mechanotransduction and cardiac hypertrophy and lays groundwork for the development of pharmacological approaches as well as for discovering potential circulating biomarkers of cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Ovchinnikova et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: